Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
5.46
-0.17 (-3.02%)
Apr 29, 2026, 12:56 PM EDT - Market open
Polaryx Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -8.99 | -30.36 | -3.78 |
| Stock-Based Compensation | 4.73 | 2.4 | 3.24 |
| Other Operating Activities | - | 26 | - |
| Change in Accounts Payable | 0.4 | -0.4 | -0.05 |
| Change in Other Net Operating Assets | -0.08 | -0.22 | 0.42 |
| Operating Cash Flow | -3.94 | -2.57 | -0.17 |
| Short-Term Debt Issued | - | 0.07 | 0.13 |
| Total Debt Issued | - | 0.07 | 0.13 |
| Short-Term Debt Repaid | - | -0.19 | - |
| Total Debt Repaid | - | -0.19 | - |
| Net Debt Issued (Repaid) | - | -0.13 | 0.13 |
| Issuance of Common Stock | 4.49 | 7.32 | - |
| Other Financing Activities | -0.03 | - | - |
| Financing Cash Flow | 4.47 | 7.19 | 0.13 |
| Net Cash Flow | 0.52 | 4.62 | -0.05 |
| Levered Free Cash Flow | 0.51 | 0.99 | - |
| Unlevered Free Cash Flow | 0.51 | 0.99 | - |
| Change in Working Capital | 0.32 | -0.62 | 0.37 |
Source: S&P Capital IQ. Standard template.
Financial Sources.